Gene expression profiling data and functional studies revealed that development of multiple myeloma (MM) is frequently associated with mutations resulting in enhanced NFκB signaling particularly via the alternative NFκB pathway [219,220,221,222]. Here, NFKB1 is linked to AL amyloidosis.